Literature DB >> 24688253

Current practice pattern for dry eye patients in South Korea: a multicenter study.

Jong Suk Song1, Joon Young Hyon2, Doh Lee3, Euisang Chung4, Chulyoung Choi4, Jeongbok Lee5, Hyo Myung Kim1.   

Abstract

PURPOSE: To assess current practice patterns for dry eye patients in South Korea and to evaluate the preference according to the ages and clinic types of physicians.
METHODS: Dry eye patients (n = 1,612) were enrolled in this multicenter cross-sectional, observational study. The severity level of dry eye patients was classified based on the Korean guidelines for dry eye treatment. The medical records of the enrolled dry eye patients were evaluated, and the practice styles and the preferences were analyzed according to the ages and clinic types of physicians.
RESULTS: Of all patients, dry eye level 1 was most common (47.5%), followed by level 2 (33.5%), level 3 (9.1%), and level 4 (1.1%). Topical anti-inflammatory agents were used in 70.7% of patients with dry eye level 2 and in 80.6% of patients at levels 3 and 4. Topical anti-inflammatory agents were also used in 48.7% of patients with dry eye level 1. Preservative-free artificial tears were preferred at all dry eye levels. The use of topical anti-inflammatory agents did not differ with investigator ages, but older physicians preferred preserved artificial tears more than younger ones. Physicians at referral hospitals also tended to use topical anti-inflammatory agents and preservative-free artificial tears earlier, beginning at dry eye level 1, than those who worked at private eye clinics.
CONCLUSIONS: Topical anti-inflammatory agents were commonly prescribed for the treatment of dry eye patients in South Korea, even from dry eye level 1. Preservative-free artificial tears were preferred at all dry eye levels. Practice styles differed somewhat depending on the ages and clinic types of physicians.

Entities:  

Keywords:  Anti-inflammatory agents; Cyclosporine A; Dry eye syndrome; Practice pattern

Mesh:

Substances:

Year:  2014        PMID: 24688253      PMCID: PMC3958626          DOI: 10.3341/kjo.2014.28.2.115

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  16 in total

1.  Conjunctival epithelium expression of HLA-DR in dry eye patients.

Authors:  K Tsubota; T Fujihara; K Saito; T Takeuchi
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

Review 2.  Adverse external ocular effects of topical ophthalmic medications.

Authors:  F M Wilson
Journal:  Surv Ophthalmol       Date:  1979 Sep-Oct       Impact factor: 6.048

3.  Cytotoxicity of ophthalmic preservatives.

Authors:  A R Gasset; Y Ishii; H E Kaufman; T Miller
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

4.  Simultaneous evaluation of tear turnover and corneal epithelial permeability by fluorophotometry in normal subjects and patients with keratoconjunctivitis sicca (KCS).

Authors:  J D Nelson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.

Authors:  K Turner; S C Pflugfelder; Z Ji; W J Feuer; M Stern; B L Reis
Journal:  Cornea       Date:  2000-07       Impact factor: 2.651

6.  Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.

Authors:  S C Pflugfelder; D Jones; Z Ji; A Afonso; D Monroy
Journal:  Curr Eye Res       Date:  1999-09       Impact factor: 2.424

Review 7.  The pathology of dry eye.

Authors:  C Baudouin
Journal:  Surv Ophthalmol       Date:  2001-03       Impact factor: 6.048

8.  Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.

Authors:  Kathleen S Kunert; Ann S Tisdale; Ilene K Gipson
Journal:  Arch Ophthalmol       Date:  2002-03

Review 9.  Management of dysfunctional tear syndrome: a Canadian consensus.

Authors:  W Bruce Jackson
Journal:  Can J Ophthalmol       Date:  2009-08       Impact factor: 1.882

Review 10.  Corneal cytotoxicity of topically applied drugs, vehicles and preservatives.

Authors:  N L Burstein
Journal:  Surv Ophthalmol       Date:  1980 Jul-Aug       Impact factor: 6.048

View more
  5 in total

1.  A multicenter cross-sectional survey of dry eye clinical characteristics and practice patterns in Korea: the DECS-K study.

Authors:  Youngsub Eom; Joon Young Hyon; Hyung Keun Lee; Jong Suk Song; Hyo Myung Kim
Journal:  Jpn J Ophthalmol       Date:  2021-01-19       Impact factor: 2.447

2.  The Effect of TNF-α Blocker HL036337 and Its Best Concentration to Inhibit Dry Eye Inflammation.

Authors:  Wungrak Choi; Hyemi Noh; Areum Yeo; Hanmil Jang; Hyea Kyung Ahn; Yeon Jung Song; Hyung Keun Lee
Journal:  Korean J Ophthalmol       Date:  2016-07-21

3.  The correction of conjunctivochalasis using high-frequency radiowave electrosurgery improves dry eye disease.

Authors:  Yong Woo Ji; Hyojin Seong; Sujung Lee; Mutlaq Hamad Alotaibi; Tae-Im Kim; Hyung Keun Lee; Kyoung Yul Seo
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

Review 4.  Dry eye: why artificial tears are not always the answer.

Authors:  Minji Kim; Yonghoon Lee; Divy Mehra; Alfonso L Sabater; Anat Galor
Journal:  BMJ Open Ophthalmol       Date:  2021-04-08

Review 5.  Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye.

Authors:  Tatiana Deveney; Penny A Asbell
Journal:  Clin Ophthalmol       Date:  2018-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.